Related Experiment Video
Updated: Oct 24, 2025
11:05
SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
15.7K
Identifying, Assessing, and Treating Korsakoff Syndrome Patients: Updated Perspectives
Joseph John Westermeyer, Beverly Soukup1, Jessica Mayer1
1Minneapolis VA Health Care Center, Minneapolis.
The Journal of Nervous and Mental Disease
|August 16, 2021
Summary
This review updates knowledge on Wernicke-Korsakoff syndrome (WKS) recognition, assessment, and care. Enhanced understanding aids patients, families, clinicians, and public health experts in managing this neurological condition.
Area of Science:
- Neurology
- Internal Medicine
- Public Health
Background:
- Wernicke-Korsakoff syndrome (WKS) is a serious neurological condition often linked to thiamine deficiency.
- Existing literature requires updating to reflect current understanding and management strategies.
Purpose of the Study:
- To provide an updated overview of Wernicke-Korsakoff syndrome (WKS).
- To cover recognition, assessment, and patient care.
- To highlight recent advancements and research.
Main Methods:
- Systematic review of recent WKS publications.
- Definition of key terminology and clinical features.
- Inclusion of illustrative case examples.
Main Results:
- Updated information on WKS epidemiology and common precipitants.
- Review of neuroimaging findings and adjunctive treatment options.
- Exploration of alternative learning strategies and future research directions.
Conclusions:
- This updated knowledge benefits patients, families, clinicians, and public health officials.
- Countries with high alcohol consumption are encouraged to establish WKS research centers and clinical facilities.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
274
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
274
01:24Treatment Strategies for Psychological Disorders
365
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
365
01:28Drug Therapy
121
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
121
01:28Psychosis and Antipsychotic Drugs: Overview
552
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
552
01:22Alzheimer's Disease: Treatment
412
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
412
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.2K